Bradsaúde (SAUD3) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Net revenues reached BRL 2.4 billion (R$2,353 million) for JUL24–JUN25, with nearly 9 million beneficiaries and a network of 27,000 dentists across 2,500 cities, outpacing industry peers in growth and diversification.
Record SME client growth: 170,000 new in 12 months, 90,000 in half-year, and 54,000 in the quarter, with higher average ticket and competitive DLR.
Net income for the last twelve months was BRL 569 million, up 18.1% YoY, with a 9.6% CAGR since IPO.
Asset-light, pre-paid, recurring revenue model with low capex, zero debt since foundation, and strong ESG credentials.
Professional management, high corporate governance, and a 95%+ payout ratio over the last decade.
Financial highlights
Adjusted EBITDA for the last twelve months was R$761 million, up 27% in the quarter, with margin rising to 34.1% in 2Q25 and 32.3% for the period.
Revenue up 8% YoY in 2Q25, driven by a 5% increase in average ticket and favorable sales mix.
Cost of services and average ticket outperformed inflation, supporting differentiated margins.
Bad debt ratio dropped to 1.2% of NOR in 2Q25, attributed to increased bankarization and efficient credit filters.
Net cash position at R$923 million as of June 2025, with zero debt and ROE of 43% in the last 12 months.
Outlook and guidance
SME and Individual plans segment continues to drive growth, with revenue CAGR of 12% since 2014 and high growth potential in non-corporate segments.
Corporate segment anticipated to rebound in the second half, with contracted wins expected to offset earlier losses.
G&A efficiency expected to improve over the next 1-2 years due to digitalization and automation investments.
Dividend and IOC payments for 2025 projected to reach R$635 million.
Focus on expanding distribution channels and leveraging digital initiatives for future growth.
Latest events from Bradsaúde
- Record net income and margin expansion driven by SME/Individual growth and strong cash position.SAUD3
Q3 20242 Jul 2026 - Revenue up 5.9%, net income R$539M, 97% payout, R$913M net cash, no debt.SAUD3
Q4 20242 Jul 2026 - 2Q24 delivered strong growth, record margins, and a 100% net income payout to shareholders.SAUD3
Q2 20242 Jul 2026 - R$13.4B revenue and R$1.3B net income in 1Q26, with robust growth and major restructuring.SAUD3
Q1 202621 May 2026 - Membership and revenue growth fueled margin expansion and strong cash generation in 2025.SAUD3
Q4 20258 Apr 2026 - High-margin, tech-focused dental insurer grows SME segment, sustains top dividends, and zero debt.SAUD3
Status update28 Jan 2026 - EBITDA margin rose to 38.3% in Q1 2025, led by SME and individual segment growth.SAUD3
Q1 202519 Nov 2025 - Record SME and Individual plan growth drove revenue, margin, and shareholder return gains.SAUD3
Q3 202513 Nov 2025